...
The Patient/Member Subgroup underwent a transition in leadership in January and again in June, so we are again in the midst of a leadership pivot. Since the start of this quarter, subgroup membership has been surveyed on topics to investigate, and we believe to be settling around a work effort that will investigate the workflow of clinical trials utilizing blockchain technologies as Hyperledger Frameworks as a means to harmonize and integrate disparate clinical trial management software (CTMS) solutions. The first focus is the Informed Patient Consent process.
Payer Subgroup
The Payer Subgroup continues to work on the white paper and refine the use cases and to ensure the right use cases are being selected for POCs.
...
With the shift to new leadership in June, the subgroup team has been active in identifying a clinical trials use case. The plan for this upcoming quarter will be to explore and mature the use case to a point where a POC for Informed Consent Process can be defined and requirements expressed. A very preliminary architecture is already in place.. Standardization of API`s and Hyperledger Solutions is a high priority. Great participation from different cultures; (including, but not limited to, East & West Coast US, England, Switzerland, Hong Kong, Argentina, and India).
Completed:
- The use case for the Informed Patient Consent process is fixed
- Two high level preliminary solution architectures are already in place.
- Regulatory compliance is already discussed and compliance governance is defined
- GitHub Repo`s are proposed
- Proposals to two conferences were sent. A lessons learned paper is to be prepared
Payer Subgroup
- We are looking to expand the membership to include team members
- Finalize the POC/Prototype for a use case and kick off that effort in this upcoming quarter
...
This is a very diverse membership with global representation (including, but not limited to, member participation from West Coast US, England, Canada, Switzerland, Hong Kong, and India). The majority of membership represents corporate healthcare entities, though we do regularly see regular (and perhaps increasingly so) participation from smaller healthcare startups.
...